References
  1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110-2121.
  2. Duarte-Delgado NP, Vasquez G, Ortiz-Reyes BL. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifes tations of neuropsychiatric systemic lupus erythematosus. Autoimmun Rev. 2019;18(4):426-432.
  3. Stummvoll GH, Aringer M, Smolen JS, et al. IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study. Ann Rheum Dis. 2005;64(7):1015-1021.
  4. Braun N, Erley C, Klein R, et al. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus. Nephrol Dial Transplant. 2000;15(9):1367-1372.
  5. Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclopho sphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001;135(4):248-257.
  6. Lewis EJ, Hunsicker LG, Lan SP, et al. A controlled trial of plasmapheresis th erapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med. 1992;326(21):1373-1379.
  7. Stummvoll GH, Aringer M, Jansen M, et al. Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy. Wien Klin Wochenschr. 2004;116(21-22):716-724.
  8. Zirkzee EJ, Huizinga TW, Bollen EL, et al. Mortality in neuropsychiatric system mic lupus erythematosus (NPSLE). Lupus. 2014;23(1):31-38.
  9. Postal M, Lapa AT, Reis F, et al. Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches. Lupus. 2017;26(5):517-521.
  10. Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: path ogenesis and biomarkers. Nat Rev Neurol. 2014;10(10):579-596.
  11. Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol. 2014;10(6):338-347.
  12. Yaniv G, Twig G, Shor DB, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14(1):75-79.
  13. Ho RC, Thiaghu C, Ong H, et al. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. Autoi- mmun Rev. 2016;15(2):124-138.
  14. Antozzi C, Berta E, Confalonieri P, et al. Protein-A immunoadsorption in immunosuppression-resistant myasthenia gravis. Lancet. 1994;343(8889):124.
  15. Griveas I, Sourgounis A, Visvardis G, et al. Immunoadsorption in lupus myocarditis. Ther Apher Dial. 2004;8(4):281-285.
  16. Maillard N, Absi L, Claisse G, et al. Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies. Blood Purif. 2015;40(2):167-172.
  17. Braun N, Gutenberger S, Erley C M, et al. Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose. Transfus Sci. 1998;19 Suppl:25-31.